|
Match
|
Document |
Document Title |
|
|
7074417 |
Multiple-delayed release anti-viral product, use and formulation thereof
An anti-viral product is comprised of at least three delayed release dosage forms, each of which has a different release profile, with the C max for the anti-viral product being reached in less...
|
|
|
7074427 |
Medicine, carrier for medicine, method of producing medicine, and method of tumor treatment
A medicinal preparation capable of lowering the threshold of cavitation and generating active oxygen species via acoustic cavitation caused by an ultrasound is provided. The preparation, which is...
|
|
|
7074389 |
Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (COPD)
The invention describes a means for the treatment of diseases of the tracheo-bronchial tract, particularly of COPD.
|
|
|
7074386 |
Pressure induced swelling in microporous materials
A method for capturing specified materials which includes contacting a microporous material with a hydrostatic fluid having at least one specified material carried therein, under pressure which...
|
|
|
7074428 |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
The present invention pertains to a quick disintegrating tablet in buccal cavity, characterized in that drug-containing particles with a mean particle diameter of approximately 50 to approximately...
|
|
|
7074395 |
Cosmetic formulations of quaternary ammonium compounds incorporating polyhydric alcohols
Cosmetic, dermatological and pharmaceutical compositions containing quaternary ammonium compounds, particularly for hair-treatment, require low setting points, good solubility and dispersibility in...
|
|
|
7070762 |
Delivery of analgesics through an inhalation route
The present invention relates to the delivery of analgesics through an inhalation route. Specifically, it relates to aerosols containing acetaminophen, orphenadrine or tramadol that are used in...
|
|
|
7070761 |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
The present invention relates to the delivery of nonsteroidal antiinflammatory drugs (NSAIDs) through an inhalation route. Specifically, it relates to aerosols containing NSAIDs that are used in...
|
|
|
7070763 |
Delivery of diphenhydramine through an inhalation route
The present invention relates to the delivery of diphenhydramine through an inhalation route. In a composition aspect of the present invention, a composition of a diphenhydramine condensation...
|
|
|
7070765 |
Delivery of drug esters through an inhalation route
The present invention relates to the delivery of drug esters through an inhalation route. Specifically, it relates to aerosols containing drug esters that are used in inhalation therapy. In a...
|
|
|
7070764 |
Delivery of analgesics through an inhalation route
The present invention relates to the delivery of analgesics through an inhalation route. Specifically, it relates to aerosols containing acetaminophen, orphenadrine or tramadol that are used in...
|
|
|
7070810 |
Use of buckysome or carbon nanotube for drug delivery
Compositions and methods for administering a therapeutic agent to a mammal are disclosed. The compositions comprise either (i) vesicles comprising an amphiphilic substituted fullerene, wherein the...
|
|
|
7071228 |
Method of treating musculoskeletal and connective tissue inflammations
A method of treating said musculoskeletal and connective tissue inflammations including osteoarthritis and associated articular and periarticular inflammations, and non-articular Rheumatism...
|
|
|
7070812 |
Process for producing dry powders of one or more carotenoids
The invention relates to a process for producing dry powders of one or more carotenoids by a) dispersing one or more carotenoids in an aqueous molecular or colloidal solution of a mixture of...
|
|
|
7070809 |
Hydrogel biomedical articles
Hydrogel biomedical articles formed from macromers having a polymeric backbone comprising 1,2-diol and/or 1,3-diol units, such as polyvinyl alcohol, and pendant chains bearing crosslinkable groups...
|
|
|
7070811 |
Directly compressible formulations of azithromycin
The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable...
|
|
|
7070800 |
Inhalable powder containing tiotropium
The invention relates to powdered preparations containing tiotropium for inhalation, processes for preparing them as well as their use in preparing a pharmaceutical composition for the treatment of...
|
|
|
7067149 |
Fast disintegrating tablet
The invention concerns an improved multiparticulate tablet disintegrating in the mouth in contact with saliva in less than 40 seconds. The invention is characterized in that it is based on...
|
|
|
7067114 |
Delivery of antihistamines through an inhalation route
The present invention relates to the delivery of antihistamines through an inhalation route. Specifically, it relates to aerosols containing antihistamines that are used in inhalation therapy. In a...
|
|
|
7067157 |
Flaky α-alumina particles and method for producing the same
Flake-like α-alumina particles having an average major diameter of 0.5 to 25 μm and an aspect ratio, expressed by particle major diameter/average thickness, of greater than 50 to 2000 and having...
|
|
|
7067140 |
Cosmetic composition
A non-aqueous cosmetic composition contains (A) activated zeolite, (B) a polyhydric alcohol having a molecular weight not higher than 1,000, and (C) a high molecular compound soluble in the...
|
|
|
7067154 |
Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use
Described herein is a pharmaceutical composition containing Vitamin D and calcium, comprising a binding agent chosen from among the group consisting of: propylene glycol, a polyethylene glycol...
|
|
|
7067153 |
Microcapsule powder
A process for making hydrophobicized powders of micro- and/or nanocapsules involving the steps of: (a) providing an aqueous polymer solution containing at least one active ingredient and at least...
|
|
|
7067162 |
Use of odorants to alter blood flow to the vagina
A non-invasive method of altering vaginal blood flow in a female individual to augment or lessen sexual arousal is provided. The method involves administering an individual odorant or odorant...
|
|
|
7067145 |
Use of arachidonic acid for enhanced culturing of fish larvae and broodstock
A method of enhancing a culturing characteristic of fish larvae, including administering to said larvae in a nutritional diet essential fatty acids including DHA and AA in a ratio effective to...
|
|
|
7063864 |
Morphine sulphate microgranules, method for preparing same and compositions containing same
The present invention concerns a novel sustained-release oral formulation of morphine sulphate in the form of microgranules. Each microgranule comprises a neutral support grain coated with an...
|
|
|
7063832 |
Delivery of muscle relaxants through an inhalation route
The present invention relates to the delivery of muscle relaxants through an inhalation route. Specifically, it relates to aerosols containing muscle relaxants that are used in inhalation therapy....
|
|
|
7063830 |
Delivery of anti-migraine compounds through an inhalation route
The present invention relates to the delivery of anti-migraine compounds through an inhalation route. Specifically, it relates to aerosols containing lidocaine, verapamil, diltiazem, isometheptene,...
|
|
|
7064101 |
Stable astaxanthin-containing powdery compositions and process for producing the same
The present invention relates to a stable astaxanthin-containing powdery composition which is obtained by drying a suspension containing a ground Haematococcus alga containing astaxanthin, a...
|
|
|
7060263 |
Super absorption Coenzyme Q10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q 10 molecules presented to the absorption channels of the small intestines by providing medium chain...
|
|
|
7060298 |
Implantable particles for the treatment of gastroesophageal reflux disease
The invention encompasses the treatment of urinary incontinence, gastroesophageal reflux disease and the amelioration of skin wrinkles using biocompatible hydrophilic cationic microparticles and a...
|
|
|
7060295 |
Formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
The compositions and dosage forms of the invention are clinically useful as methods for increasing the effectiveness, efficiency and safety of biguanides (metformin) and/or sulfonylureas in the...
|
|
|
7060255 |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
The present invention relates to the delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route. Specifically, it relates to aerosols containing alprazolam, estazolam,...
|
|
|
7056503 |
Enclosures housing cell-coated supports for treating tumors
The present invention relates to devices, systems and methods for treating tumors. In particular, the present invention relates to enclosures housing cell-coated supports for promoting regression...
|
|
|
7056495 |
Solid dose delivery vehicle and methods of making same
The present invention encompasses a solid dose delivery vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and...
|
|
|
7056535 |
Triggered release from proteinoid microspheres
The invention provides proteinoid microsphere made up of a mixture of thermally condensed amino acids that are crosslinked with a bis dithiol crosslinker reagent. The proteinoid microspheres of the...
|
|
|
7056534 |
Coated potassium chloride granules and tablets
This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20–60 mesh that are coated only with...
|
|
|
7056525 |
Carotenoid formulations, comprising a mixture of β-carotene, lycopene and lutein
Carotenoid formulations comprising a mixture of β-carotene, lycopene and lutein, and the use thereof in human and animal foods, cosmetics and pharmaceuticals.
|
|
|
7056554 |
Production of polyelectrolyte capsules by surface precipitation
The invention concerns a method for producing nanocapsules and microcapsules comprising a polyelectrolyte shell by surface precipitation from the solution, by applying a shell to template particles...
|
|
|
7052679 |
Delivery of antipsychotics through an inhalation route
The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a...
|
|
|
7052718 |
Metal oxide-organopolysiloxane hybrid powder and a method for the preparation thereof and a cosmetic composition therewith
The present invention is to provide a metal oxide.organopolysiloxane hybrid powder, wherein a silicon atom of organopolysiloxane is bonded by covalent bond with a metal atom through an oxygen atom...
|
|
|
7052719 |
Matrices formed of polymer and hydrophobic compounds for use in drug delivery
A lipid or other hydrophobic or amphiphilic compound (collectively referred to herein as “hydrophobic compounds”) is integrated into a polymeric matrix for drug delivery to alter drug release...
|
|
|
7052712 |
Animal feeds including actives and methods of preparing same
Improved extrusion-processed daily ration animal feeds are provided which include minor amounts of actives to ensure that an animal consuming the feed receives quantities of the actives sufficient...
|
|
|
7052678 |
Particles for inhalation having sustained release properties
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to...
|
|
|
7052680 |
Delivery of compounds for the treatment of Parkinsons through an inhalation route
The present invention relates to the delivery of antiparkinsons drugs through an inhalation route. In a method aspect of the present invention, an antiparkinsons drug is administered to a patient...
|
|
|
7048947 |
Sustained-release preparation
A sustained-release preparation which comprises a physiologically active peptide of general formula
wherein X represents an acyl group;
R 1 , R 2 and R 4 each represents an aromatic cyclic...
|
|
|
7049346 |
Swollen hydrogel for sphincter augmentation
A physiologically acceptable composition comprises a plurality of physiologically acceptable hydrogel particles which have been swollen in a water solution containing a low molecular weight water...
|
|
|
7048909 |
Delivery of beta-blockers through an inhalation route
The present invention relates to aerosols containing of atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy. In a method aspect of the present invention, of...
|
|
|
7048908 |
Particles for inhalation having sustained release properties
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to...
|
|
|
7048948 |
Stable granulates containing S-adenosylmethionine and process for the preparation thereof
A fluid bed granulation process for manufacturing non-hygroscopic, stable granulates containing a water-soluble salt of S-adenosylmethionine is described. Said process comprises:
a) the...
|